Umban, Shirlyn A.

HRN: 29-08-33  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/17/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/17/2026
06/23/2026
IV
600mg
Q8
Necrotizing Faciitis
Checking Initial Appropriateness 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines